Catalog No.
DHJ49901
Expression system
Mammalian Cells
Species reactivity
Human
Host species
Human
Isotype
IgG
Target
DIL-1, SPON2, Mindin, DIL1, Differentially expressed in cancerous and non-cancerous lung cells 1, Spondin-2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
Q9BUD6
Applications
Research Grade Biosimilar
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
19G9
A tri-compound formula comprising Ginsenoside Rg1, tetrandrine and icariin alleviates atopic dermatitis symptoms in a mouse model., PMID:40222169
The h4 coil surface region of human papillomavirus type 58 L1 virus-like particle serves as a potential location for presenting the RG1 epitope peptide., PMID:40170153
Puzzling Late Relapse of Thyroid Eye Disease: A Case Series., PMID:40144476
Unveiling cardiovascular and respiratory toxicities with monoclonal antibodies in multiple myeloma: disproportionality analysis from the FDA Adverse Event Reporting System., PMID:40095047
Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice., PMID:39632208
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database., PMID:38489062
Reprogramming of astrocytes to neuronal-like cells in spinal cord injury: a systematic review., PMID:38448665
Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies., PMID:38225646
Development and optimisation of a reception testing protocol designed to eliminate HCV in the UK prison population., PMID:38169900
Alum and a TLR7 agonist combined with built-in TLR4 and 5 agonists synergistically enhance immune responses against HPV RG1 epitope., PMID:37798448
Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model., PMID:37270364
Challenges in liver transplantation in the context of a major pandemic., PMID:36437846
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development., PMID:36263027
Escherichia coli Heat-Labile Enterotoxin B Subunit Combined with Ginsenoside Rg1 as an Intranasal Adjuvant Triggers Type I Interferon Signaling Pathway and Enhances Adaptive Immune Responses to an Inactivated PRRSV Vaccine in ICR Mice., PMID:33809809
RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates., PMID:33802456
Efficacy of Rg1-Oil Adjuvant on Inducing Immune Responses against Bordetella bronchiseptica in Rabbits., PMID:33575363
Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP., PMID:33573433
Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine., PMID:33476764
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists., PMID:33309485
Protective effect of ginsenoside Rg1 on attenuating anti-GBM glomerular nephritis by activating NRF2 signalling., PMID:31322005
A rationally designed flagellin-L2 fusion protein induced serum and mucosal neutralizing antibodies against multiple HPV types., PMID:31213378
Incorporation of RG1 epitope into HPV16L1-VLP does not compromise L1-specific immunity., PMID:31147274
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine., PMID:30918267
Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus., PMID:29743371
Ginsenoside Rg1 enhanced immune responses to infectious bursal disease vaccine in chickens with oxidative stress induced by cyclophosphamide., PMID:29660049
Qualitative detection of ginsenosides in brain tissues after oral administration of high-purity ginseng total saponins by using polyclonal antibody against ginsenosides., PMID:29576053
Regulatory effects of four ginsenoside monomers in humoral immunity of systemic lupus erythematosus., PMID:29434811
Time to ask patients about drugs for macular degeneration., PMID:29184013
Ginsenoside Rg1 nanoparticle penetrating the blood-brain barrier to improve the cerebral function of diabetic rats complicated with cerebral infarction., PMID:28919749
Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies., PMID:28855937
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes., PMID:28778613
Ginsenoside Rg1 Protects against Oxidative Stress-induced Neuronal Apoptosis through Myosin IIA-actin Related Cytoskeletal Reorganization., PMID:27877086
Lipidated L2 epitope repeats fused with a single-chain antibody fragment targeting human FcγRI elicited cross-neutralizing antibodies against a broad spectrum of human papillomavirus types., PMID:27729176
Ginsenoside Rg1 and 20(S)-Rg3 Induce IgA Production by Mouse B Cells., PMID:26770188
Preparation of a Monoclonal Antibody against Gintonin and Its Use in an Enzyme Immunoassay., PMID:26424022
Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development., PMID:26134615
Ginsenoside Rg1 relieves tert-Butyl hydroperoxide-induced cell impairment in mouse microglial BV2 cells., PMID:25971787
CD8+ TCR Bias and Immunodominance in HIV-1 Infection., PMID:25911754
Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay., PMID:25828731
A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types., PMID:25790098
Developmental changes in guard cell wall structure and pectin composition in the moss Funaria: implications for function and evolution of stomata., PMID:25129633
Preparation of a monoclonal antibody against notoginsenoside R1, a distinctive saponin from Panax notoginseng, and its application to indirect competitive ELISA., PMID:24610346
Reclassification of diabetes etiology in a family with multiple diabetes phenotypes., PMID:24606082
Efficacy of RG1-VLP vaccination against infections with genital and cutaneous human papillomaviruses., PMID:23752042
Beneficial effects of ginsenoside-Rg1 on ischemia-induced angiogenesis in diabetic mice., PMID:23111241
Effects of ginsenoside Re on LPS-induced inflammatory mediators in BV2 microglial cells., PMID:23102375
Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique., PMID:23001256
Eastern blotting analysis and isolation of two new dammarane-type saponins from American ginseng., PMID:22863873
Application of Monoclonal Antibodies against Bioactive Natural Products: Eastern Blotting and Preparation of Knockout Extract., PMID:22518137
Development of a secondary antibody thio-functionalized microcantilever immunosensor and an ELISA for measuring ginsenoside Re content in the herb ginseng., PMID:22494059
For research use only. Not for human or drug use.
